[¹⁷⁷Lu]Lutetium-labelled PSMA ligand-induced remission in a patient with metastatic prostate cancer. (Q53031483)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25573634%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

title

[¹⁷⁷Lu]Lutetium-labelled PSMA ligand-induced remission in a patient with metastatic prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25573634%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25573634%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

6

Walter Mier

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25573634%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

5

Martina Benešová

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25573634%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

author name string

Clemens Kratochwil

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25573634%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Frederik L Giesel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25573634%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Matthias Eder

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25573634%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Klaus Kopka

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25573634%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Uwe Haberkorn

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25573634%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

publication date

9 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25573634%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Nuclear Medicine and Molecular Imaging

27 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25573634%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25573634%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25573634%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

987-988

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25573634%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00259-014-2978-1

27 February 2020

exact match

0 references

cites work

Expression of prostate-specific membrane antigen in normal, benign, and malignant prostate tissues

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2978-1

Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2978-1

Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2978-1

Radiation dosimetry and first therapy results with a (124)I/ (131)I-labeled small molecule (MIP-1095) targeting PSMA for prostate cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00259-014-2978-1

Constitutive and antibody-induced internalization of prostate-specific membrane antigen.

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25573634